News articles for Romark Laboratories, L.C.:
Thursday, April 18, 2013
Romark Laboratories Initiates Phase 3 Trial of New Influenza Drug
TAMPA, Fla., April 18, 2013 /PRNewswire/ -- Romark Laboratories announced that it has begun enrolling patients in a global Phase 3 clinical trial of NT-300 (nitazoxanide) for treatment of acute uncomplicated influenza.
(Logo: http://photos.prnewswire.com/prnh/20100201/FL47022LOGO )
The Phase 3 clinical trial has been initiated in the United States, ... read more
Thursday, February 28, 2013